CN111534499A

CN111534499A - GGPPS directed single point mutant protein GGPPS-233

Info

Publication number: CN111534499A
Application number: CN202010467100.0A
Authority: CN
Inventors: 郭敬功; 苗雨晨; 李坤; 许锐; 贾昆鹏; 孙旭武; 李伟强
Original assignee: Henan University
Current assignee: Henan University
Priority date: 2020-05-28
Filing date: 2020-05-28
Publication date: 2020-08-14

Abstract

The application belongs to the technical field of tobacco genetic engineering, and particularly relates to a GGPSP directional mutant protein patent application affair. The three sites 154, 161 and 218 of the existing GGPPS protein are positioned in the catalytic pocket of the enzyme, and the two sites 209 and 233 are positioned on the surface of the enzyme molecule; based on these five sites, the present application provides GGPPS series of targeted muteins, including: a series of single-site muteins, two-site muteins, three-site muteins, four-site muteins, and five-site muteins. The inventor utilizes CAST technology to construct a small and fine mutant library, and the inventor conducts detailed analysis on the mutation type of the amino acid at a specific position through further screening and based on the requirement of directed evolution. Preliminary experiment results show that after the amino acid at a specific site is mutated, the synthesis amount of the beta-carotene is obviously improved, and a certain technical basis is laid for further cultivating new varieties of crops.

Description

GGPPS directed single point mutant protein GGPPS-233

Technical Field

The application belongs to the technical field of tobacco genetic engineering, and particularly relates to GGPPS directional mutant protein patent application matters.

Background

The carotenoid is an important plastid pigment, has important physiological action, is closely related to the growth and development and photosynthesis of plants, and influences the quality and the characters of crops. Geranylgeranyl diphosphate (GGPP) is a common precursor for carotenoids, the phytol side chains of chlorophyll and vitamin E, gibberellins, and diterpene phytochemicals. GGPP is catalytically produced by geranylgeranyl diphosphate synthase (GGPP synthsase, GGPPS), and 3 molecules of isopentenyl pyrophosphate (IPP) and 1 molecule of allyl isomer dimethylallyl pyrophosphate (DMAPP) are condensed under the action of GGPPS to produce C20 GGPP.

GGPP is a starting substrate for carotenoid synthesis, and is catalyzed by Phytoene Synthase (PSY), a terminal enzyme of the carotenoid synthesis pathway, to form phytoene, which is used for carotenoid synthesis. A great deal of research demonstration on plant GGPPS gene family shows that the family members not only encode important enzyme proteins at the upstream of a terpene synthesis pathway, but also directly participate in regulating various pathways of plant terpene synthesis, and play a central role in regulation.

In the existing research, although the synthesis routes of carotenoids have been studied more, from the aspect of plant improvement, if the oriented breeding and cultivation can be realized by using the genetic engineering technology, the method is an important technical premise for realizing the maximum utilization of plants.

As one of the key technologies in synthetic biology, directed biological evolution technology has acquired the 2018 nobel prize on chemistry. The technology is widely used for the activity design of enzyme, and can effectively overcome the defects of natural enzyme in the aspects of environmental tolerance, stereo/regioselectivity, substrate specificity, catalytic efficiency, product inhibition and the like through directed evolution, so that the evolution process of thousands of years in the nature is completed in a laboratory in a short time.

In the development process of the directed evolution technology of the enzyme, when the traditional directed evolution is carried out, such as error-prone PCR, DNA mixed group, sequence saturation mutation, random initiation of in vitro recombination and other technologies, the defects of low mutation efficiency, large screening workload and the like exist, and the application of the in vitro directed evolution of enzyme molecules is restricted. A combined active-site mutation strategy (CAST) is a relatively new directed evolution mutation strategy, and the technology is based on structural information of protein, firstly, on the basis of simulation of a computer, then, amino acid residues which have direct interaction with a substrate are selected around an enzyme catalytic active center, and a small and fine mutant library is constructed, so that the screening scale of the mutant library is reduced.

Generally, although the directed evolution technology can accelerate the evolution process of crop genes and provide high-quality genes for improving the quality of crops, the directed evolution technology is not used for modifying plant genes at present due to short development time and other technical difficulties.

Tobacco is one of model crops for genetic engineering research, and meanwhile, the carotenoid content in tobacco directly influences the quality and the character of the tobacco. Therefore, if the directional evolution can be combined to carry out the directional transformation on the terpene synthetic genes of the tobacco, the method has very important application significance for accelerating the tobacco breeding, and simultaneously, a certain technical foundation can be laid for the genetic breeding of other crops.

Disclosure of Invention

Through the research on the structure of geranylgeranyl diphosphate synthase (GGPP synthsase, GGPPS) enzyme and the combination of the directed evolution technology, the application aims to provide a plurality of GGPPS and tobacco GGPPS genes with better enzyme activity, thereby providing a new technical thought for tobacco breeding and new tobacco variety cultivation and simultaneously laying a certain technical foundation for breeding and variety improvement of other crops.

The technical solution adopted in the present application is detailed as follows.

In the process of researching the existing GGPPS structure, the inventor considers that three sites of 154 th site, 161 th site and 218 th site of the existing GGPPS protein (the corresponding gene sequence is GenBank accession No. NM-001325177.1) are positioned in a catalytic pocket of enzyme, so that after directional mutation is carried out on amino acids of the three sites, the combination of a substrate and the enzyme activity pocket is facilitated, and the enzyme activity performance of the GGPPS is improved; the 209 th site and the 233 th site are positioned on the surface of enzyme molecules, and after directional mutation is carried out on the amino acids of the two sites, GGPPS homodimers are favorably formed, so that the stability of the protein is enhanced; based on the five sites, the inventors provide the GGPPS series of directional mutant proteins, which include: the specific introduction of the series of single-site mutant proteins, the series of double-site mutant proteins, the series of three-site mutant proteins, the series of four-site mutant proteins and the series of five-site mutant proteins is described as follows.

Single site mutations:

GGPPS directional single point mutant protein GGPPS-154, compared with the existing tobacco GGPPS protein, Val (V) at the 154 th position is mutated into neutral amino acid Ala (A) or cysteine Cys (C);

GGPPS directional single point mutant protein GGPPS-161, compared with the existing tobacco GGPPS protein, Ile (I) amino acid at position 161 is mutated into neutral aliphatic amino acid Leu (L) or into amino acid Met (M) containing sulfhydryl;

GGPPS directional single point mutant protein GGPPS-209, compared with the existing tobacco GGPPS protein, the 209 th Ile (I) amino acid is mutated into a basic amino acid Lys (K), a hydroxyl-containing amino acid Ser (S), or into any one of aspartic acid Asp (D), asparagine Asn (N), alanine Ala (A) or proline Pro (P);

GGPPS directional single point mutant protein GGPPS-218, compared with the existing tobacco GGPPS protein, the 218 th Phe (F) amino acid of the GGPPS directional single point mutant protein is mutated into aromatic amino acid tyrosine Tyr (Y) or leucine Leu (L);

GGPPS directional single-point mutant protein GGPPS-233, compared with the existing tobacco GGPPS protein, the 233 th amino acid Val of which is mutated into the acidic amino acid Glu (E) or tyrosine Tyr (Y);

the amino acid sequence of the existing tobacco GGPPS protein is shown in SEQ ID NO. 1.

In the two-site mutation:

on the basis of the unit mutation, the mutant protein formed by combining any two of the unit sites shows better enzyme activity effect, and specifically, the double-site mutant protein is, for example:

GGPPS directional double site mutant protein 209-233, compared with the existing tobacco GGPPS protein, the Ile amino acid at the 209 th site and the Val amino acid at the 233 th site are simultaneously mutated; ile (I) at the position 209 is mutated into any one of basic amino acid Lys (K), amino acid Ser (S) containing hydroxyl, aspartic acid Asp (D), asparagine Asn (N), alanine Ala (A) or proline Pro (P), and amino acid Val at the position 233 is mutated into acidic amino acid Glu (E) or tyrosine Tyr (Y);

that is, the GGPPS directed double site mutant protein 209-233 is combined at the sites 209 and 233 as follows: 209K-233E, 209S-233E, 209P-233E, 209S-233Y, 209P-233Y, or the like.

In the three-site mutation:

on the basis of the unit mutation, mutant proteins formed by any three-site combination show better enzyme activity effect, and specifically, the two-site mutant proteins are, for example:

the directional three-point mutant protein GGPPS-154-161-218, compared with the existing tobacco GGPPS protein, the Val amino acid at the 154 th position, the Ile amino acid at the 161 th position and the Phe amino acid at the 218 th position are simultaneously mutated; val (V) at position 154 mutated to the neutral amino acid Ala (A) or to cysteine Cys (C); ile (I) amino acid at position 161 is mutated into neutral aliphatic amino acid Leu (L) or is mutated into amino acid Met (M) containing sulfhydryl; phe (F) amino acid 218 mutated to the aromatic amino acid tyrosine Tyr (Y) or to leucine Leu (L);

that is, the GGPPS directed three-point mutant protein GGPPS-154-161-218 combination is: 154A-161M-218L, 154A-161M-218Y, 154A-161L-218L, 154A-161L-218Y, 154C-161M-218L, 154C-161M-218Y, 154C-161L-218L, 154C-161L-218Y, and the like.

In the five-site mutation:

on the basis of the unit mutation, mutant proteins formed by arbitrary mutation combinations of five sites all show better enzyme activity effects, and specifically, the double-site mutant proteins are, for example:

compared with the existing tobacco GGPPS protein, the directional five-site mutant protein GGPPS on the surfaces of the enzyme pocket and the enzyme molecule simultaneously mutates Val amino acid at position 154, Ile amino acid at position 161, Ile amino acid at position 209, Phe amino acid at position 218 and Val amino acid at position 233;

the five-site mutant protein GGPPS combination is as follows: 154A-161M-209K-218Y-233E, 154A-161M-209S-218Y-233E, 154A-161L-209S-218Y-233E, or 154A-161L-209K-218Y-233E, and the like.

The GGPPS directional mutant protein is applied to pigment synthesis, and is used for catalyzing GGPP to synthesize beta-carotene.

The novel crop variety breeding method based on the GGPPS series directional mutant protein coding gene is characterized in that the content of pigment substances in crops can be adjusted (increased) by recombining the GGPPS series directional mutant protein coding gene into a crop genome by using a genetic engineering technical means;

the pigment substance is beta-carotene;

the crops are as follows: tobacco, pepper, tomato, rice, corn, wheat, potato, castor-oil plant, apple, cucumber, watermelon, carrot, banana, orange, grape, coffee, ginkgo, salvia, chrysanthemum or rubber tree, etc.

GGPP is used as a precursor substance of downstream carotenoid, and the inventors show that 154, 161, 209, 218 and 233 are key sites through structural analysis of key amino acid sites of an enzyme active pocket of GGPPS. Furthermore, the inventor utilizes CAST technology to construct a small and fine mutant library, thereby overcoming the defects of low mutation rate, large screening amount and the like in the traditional directed evolution screening process. Through further screening and based on the requirement of directed evolution, the inventors have conducted detailed analysis on the types of amino acid mutations at specific sites. Preliminary experiment results show that after the amino acid at a specific site is mutated, the synthesis amount of the beta-carotene is obviously improved, and a certain technical basis is laid for further cultivating new varieties of crops.

Drawings

FIG. 1 is a bacterial color experiment of GGPPS-154 mutant, in which: a double plasmid bacteria color experiment, PAC-94N plasmid contains PSY, PDS and LCY-B three genes, IPP and DMAPP can be synthesized in Escherichia coli, but GGPP can not be produced, after GGPPS plasmid with enzyme activity and PAC-94N are jointly transformed into Escherichia coli, beta-carotene can be catalytically produced in Escherichia coli, and Escherichia coli is transformed from white to yellow; B. in the GGPPS-154 single-site mutation bacterial color experiment, the 154 th amino acid site is mutated, after the 154 th amino acid site and PAC-94N double plasmids are jointly transformed into escherichia coli BL21 (DE) 3, the color of the bacterial liquid is obviously changed after IPTG induction, the lower graph is the light absorption value at OD440, and empty pET32b is used as negative control, so that the light absorption value of the mutant at OD440 is obviously improved compared with wild type GGPPS;

FIG. 2 shows bacterial color experiments of GGPPS-161 mutant, wherein A is the same as that in FIG. 1A and is a synthetic schematic diagram, and B is bacterial color experiments of single-site mutation of GGPPS-161;

FIG. 3 shows bacterial color experiments of GGPPS-218 mutant, wherein A is the same as that in FIG. 1A and is a synthetic schematic diagram, and B is bacterial color experiments of single-site mutation of GGPPS-218;

FIG. 4 shows bacterial color experiments of GGPPS-209 mutant, wherein A is the same as that in FIG. 1A and is a synthetic principle diagram, and B is bacterial color experiments of single-site mutation of GGPPS-209;

FIG. 5 shows bacterial color experiments of GGPPS-233 mutant, wherein A is the same as FIG. 1A and is a synthetic schematic diagram, and B is bacterial color experiments of single-site mutation of GGPPS-233;

FIG. 6 shows bacterial color experiments of GGPPS-154/161/218 mutant, wherein A is the same as that in FIG. 1A and is a synthetic schematic diagram, and B is bacterial color experiments of GGPPS-154/161/218 three-site combined mutation;

FIG. 7 shows bacterial color experiments of GGPPS-209/233 mutant, wherein A is the same as that in FIG. 1A and is a synthetic schematic diagram, and B is bacterial color experiments of two-site combined mutation of GGPPS-209/233;

FIG. 8 shows bacterial color experiments of GGPPS-154/161/209/218/233 mutant, wherein A is the same as that in FIG. 1A and is a synthetic principle diagram, and B is bacterial color experiments of combined mutation of five sites of GGPPS-154/161/209/218/233.

FIG. 9 is a comparison of GGPPS-154 and GGPPS locus of the mainstream crop, in which: hot pepper (cagggpps 1), potato (StGGPPS 1), wheat (tagggpps 1), corn (ZmGGPPS 1), salvia miltiorrhiza (SmGGPPS 1), coffee (CanGGPPS 1), carrot (DcGGPPS 1), grape (VvGGPPS), cucumber (csagpps), watermelon (ClGGPPS), apple (MdGGPPS 1), orange (csigpps), rubber tree (HbGGPPS), chrysanthemum (CmGGPPS), rice (OsGGPPS 1), tomato (SlGGPPS 1), castor (rcgggpps), banana (magggpps) and ginkgo biloba (GbGGPPS).

Detailed Description

The present application is further explained below with reference to the drawings and examples.

Example 1

Since the acquisition of the existing geranylgeranyl diphosphate synthase (GGPPS) gene is the basis of the analysis of the relevant sequences and the directed evolution mutation, this example is summarized below with respect to the cloning acquisition of the existing geranylgeranyl diphosphate synthase (GGPPS) gene.

First, based on the gene sequence shown in GenBank accession No. NM _001325177.1, primer sequences for PCR amplification were designed as follows:

a forward primer: 5'-atgagatctatgaatcttgt-3' the flow of the air in the air conditioner,

reverse primer: 5'-attttcacgataagcaatgt-3', respectively;

performing PCR amplification by taking tobacco K326 leaf cDNA as a template;

carrying out electrophoresis detection on the PCR amplification product, recovering and purifying, and connecting the recovered and purified PCR product with pGEMT plasmid;

subsequently, the ligation product was transformed into E.coli DH 5. alpha. competent cells, and after overnight culture, positive clones were selected and identified to obtain the recombinant correct cloning plasmid pGEMT-GGPPS.

In order to facilitate the subsequent expression of GGPPS, the inventor further constructs a recombinant expression vector by utilizing pET-32b (+) plasmid, and the specific process is as follows:

first, a pair of primer sequences containing Nde I and Xho I cleavage sites was designed as follows:

a forward primer: 5'-gctaatccatatgGAGCAATTCAATTTCAAAACT-3' the flow of the air in the air conditioner,

reverse primer: 5'-cagctcgagATTTTCACGATAAGCAATGTAAT-3', respectively;

then, using the clone plasmid pGEMT-GGPPS as a template to carry out PCR amplification so as to obtain a GGPPS gene, and recycling and purifying PCR amplification products;

subsequently, carrying out Nde I and Xho I double enzyme digestion on the GGPPS gene product obtained by PCR amplification and the pET-32b (+) plasmid respectively, and recovering enzyme digestion products for connection;

finally, the ligation product was transformed into DH5 α competent cells, cultured overnight, and positive clones were selected for identification, and the correctly identified recombinant expression plasmid vector was renamed: pET-32b (+) -GGPPS.

Example 2

In order to facilitate the detection and analysis of relevant mutation sites, the present application has been experimentally verified using a geranylgeranyl diphosphate synthase (GGPPS) recombinant engineered strain, and therefore, the construction process of this engineered strain is briefly described below in this example.

First, the recombinant vector pET-32b (+) -GGPPS constructed in example 1 was co-transformed with the PAC-94N plasmid to express E.coli BL21(DE3), and the empty vector pET-32b (+) was co-transformed with the PAC-94N plasmid to serve as a negative control strain;

subsequently, after overnight culture, positive clones were selected for identification, and strains of positive clones that were sequenced correctly were either preserved or subjected to further beta-carotene content testing.

The principle of detecting the content of the beta-carotene comprises the following steps: coli cannot produce GGPP by itself, and PAC-94N plasmid contains all genes of a beta-carotene synthesis pathway but does not contain geranylgeranyl diphosphate synthase encoding genes, so that when the recombinant vector pET-32b (+) -GGPPS and the PAC-94N plasmid are co-transformed, the strain which can catalytically produce GGPP is changed from white to yellow, the strain with stronger enzyme activity has deeper yellow, and the absorbance value of OD440 is further measured by a spectrophotometer, so that the content of the final product beta-carotene can be measured.

Example 3

Since no crystal structure report is available for tobacco GGPPS, the inventors have performed homologous modeling on the enzyme based on its amino acid sequence in order to analyze the protein. During modeling, the optimal template was 3kro, the score was 0.993 (TM-score was used to measure the degree of matching between two protein structure models, the score from 0 to 1, 1 means perfect match), the Root Mean Square Deviation (RMSD) was 0.36 a, the sequence Identity (IDEN) was 74.9%, and the protein structure coverage (Cov) was 99.7%.

Substrates C5-DMAPP, C10-GPP, C15-FPP were docked to the GGPPS catalytic pocket using the Rosetta _ docking program, respectively. The binding mode of the receptor small molecule compound is predicted by searching the optimal binding position for the action of the receptor small molecule compound and the enzyme. The final analysis results show that: the 154 th site, the 161 th site and the 218 th site are positioned in a catalytic pocket of the enzyme, the binding capacity of a substrate and an enzyme activity pocket can be further improved after amino acid substitution, and the sites participate in enzyme activity regulation and control; and the 209 th and 233 th amino acid sites are positioned on the surface of the enzyme molecule, which is favorable for the protein to form a dimer.

It should be noted that, the existing GGPPS consists of 296 amino acids, and the specific sequence is shown in SEQ ID No.1, which is as follows:

EQFNFKTYVAEKAISVNKALDEAVIVKDPPVIHEAMRYSLLAGGKRVRPMLCLAACELVGGDQSNAMPAACAVEMIHTMSLIHDDLPCMDNDDLRRGKPTNHKVYGEDVAVLAGDSLLAFAFEYIATATAGVSPSRILAAIGELAKSIGTEGLVAGQVADIACTGNPNVGLDTLEFIHIHKTAALLEASVVLGAILGGGTDEEVEKLRIFARCIGLLFQVVDDILDVTKSSEVLGKTAGKDLAVDKTTYPKLLGLEKAKEFAAELNRDAKQQLVEFDPHKAAPLIALADYIAYREN

the gene for coding GGPPS consists of 888 nucleotides, and the specific sequence is shown as SEQ ID No.2, and specifically comprises the following steps:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

based on the above analysis, the inventors further constructed a GGPPS saturation mutant library aiming at the 5 sites, and the specific construction process is briefly described as follows.

First, degenerate primer sequences were designed based on the above 5 sites as follows:

V154-F：5’-ggaactgaagggttannkgctggacaagtagcg-3’，

I161-F: 5’-ggacaagtagcggatnnkgcttgtactggtaac-3’，

I209-F: 5’-gtggagaaattgaggnnkttcgcgagatgtatt-3’，

F218-F: 5’-tgtattggattattgnnkcaagtagtagatgat-3’，

V233-F: 5’-acaaagtcgtcggagnnkctcggaaaaaccgcc-3’，

general-R: 5’-cacgataagcaatgtaatccg-3’；

subsequently, whole plasmid PCR was carried out using pET-32b (+) -GGPPS constructed in example 1 as a template, and then V154-F, I161-F, I209-F, F218-F and V233-F as forward primers and general-R as reverse primers, respectively;

then, the PCR amplification product was subjected to DpnI digestion, and the digested product was co-transformed with PAC-94N double plasmid into E.coli BL21(DE3) competent cells, and after the transformation, the bacterial solution was spread on a plate containing 100. mu.g/L ampicillin and 34. mu.g/L chloramphenicol, to finally obtain a saturated mutation library.

For further screening, positive monoclonals were selected, cultured overnight in 20ml of LB liquid medium containing ampicillin (100. mu.g/L) and chloramphenicol (34. mu.g/L), induced at 18 ℃ for expression with IPTG at a final concentration of 0.1mM, centrifuged after completion of the culture, the supernatant was discarded, photographed, and resuspended in 3ml of acetone, and the OD440 value was measured.

And finally screening and determining the mutant with obviously enhanced absorbance by adopting the high-throughput screening method and further sequencing. The results show that when: val (V) at position 154 mutated to the neutral amino acid Ala (A) or to cysteine Cys (C); ile (I) amino acid at position 161 is mutated into neutral aliphatic amino acid Leu (L) or is mutated into amino acid Met (M) containing sulfhydryl; ile (I) amino acid at position 209 is mutated to a basic amino acid Lys (K), an amino acid Ser (S) containing a hydroxyl group, aspartic acid Asp (D), asparagine Asn (N), alanine Ala (A) or proline Pro (P); phe (F) amino acid 218 mutated to the aromatic amino acid tyrosine Tyr (Y) or to leucine Leu (L); when the 233 th amino acid Val is mutated into acidic amino acid, the acid is Glu (E) or tyrosine Tyr (Y); the geranylgeranyl diphosphate synthase GGPPS of tobacco has obvious change.

For position 154:

when the 154 site is mutated to A, the amino acid sequence is as follows:

EQFNFKTYVAEKAISVNKALDEAVIVKDPPVIHEAMRYSLLAGGKRVRPMLCLAACELVGGDQSNAMPAACAVEMIHTMSLIHDDLPCMDNDDLRRGKPTNHKVYGEDVAVLAGDSLLAFAFEYIATATAGVSPSRILAAIGELAKSIGTEGLAAGQVADIACTGNPNVGLDTLEFIHIHKTAALLEASVVLGAILGGGTDEEVEKLRIFARCIGLLFQVVDDILDVTKSSEVLGKTAGKDLAVDKTTYPKLLGLEKAKEFAAELNRDAKQQLVEFDPHKAAPLIALADYIAYREN；

the corresponding base coding sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGCGGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT；

when the 154 site is mutated to C, the base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTATGCGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT。

for position 161:

when the 161 site is mutated to L, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATCTGGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 161 site is mutated to M, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATGGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT。

for position 218:

when the 218 site is mutated to L, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGCTGCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 218 site is mutated to Y, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTATCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT。

for site 209:

when the 209 th site is mutated to P, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGCCGTTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 209 th site is mutated to K, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGAAATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 209 th site is mutated to D, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGGATTTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 209 th site is mutated to N, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGAATTTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 209 th site is mutated to S, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGAGCTTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 209 th site is mutated to A, the coding base sequence is as follows:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGGCGTTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGTGCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT。

for position 233:

when the 233 site is mutated to E, it encodes the base sequence:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGAACTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT

when the 233 site is mutated to Y, the coding base sequence is:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGTAGCTGGACAAGTAGCGGATATAGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGATATTCGCGAGATGTATTGGATTATTGTTTCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGTATCTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT。

other two, three or five site specific base sequences can be referred to above, for example, for the five site mutant protein GGPPS-154A/161L/209S/218Y/233E, the amino acid sequence is:

EQFNFKTYVAEKAISVNKALDEAVIVKDPPVIHEAMRYSLLAGGKRVRPMLCLAACELVGGDQSNAMPAACAVEMIHTMSLIHDDLPCMDNDDLRRGKPTNHKVYGEDVAVLAGDSLLAFAFEYIATATAGVSPSRILAAIGELAKSIGTEGLAAGQVADLACTGNPNVGLDTLEFIHIHKTAALLEASVVLGAILGGGTDEEVEKLRSFARCIGLLYQVVDDILDVTKSSEELGKTAGKDLAVDKTTYPKLLGLEKAKEFAAELNRDAKQQLVEFDPHKAAPLIALADYIAYREN

in this case, the corresponding coding base sequence is:

GAGCAATTCAATTTCAAAACTTACGTAGCTGAAAAGGCTATTTCTGTAAATAAAGCTTTAGATGAGGCTGTTATAGTAAAAGACCCACCTGTGATCCACGAAGCAATGCGCTATTCACTTCTCGCCGGCGGCAAAAGAGTCCGACCGATGCTCTGCCTCGCCGCCTGCGAGCTCGTCGGCGGCGACCAATCCAACGCCATGCCGGCTGCTTGCGCCGTCGAGATGATCCACACTATGTCCCTCATTCACGACGATTTACCTTGTATGGATAACGACGATCTCCGCCGTGGAAAGCCGACGAACCACAAAGTCTACGGCGAGGACGTGGCGGTCCTCGCCGGAGACTCGCTCCTCGCTTTCGCCTTCGAGTACATCGCCACCGCTACCGCCGGAGTTTCACCGTCGAGGATCCTCGCCGCCATCGGCGAACTGGCGAAATCCATCGGAACTGAAGGGTTAGCGGCTGGACAAGTAGCGGATCTGGCTTGTACTGGTAACCCTAATGTTGGACTCGACACACTCGAATTCATTCACATACACAAAACGGCGGCGCTTCTAGAAGCTTCCGTAGTTCTCGGAGCAATCCTCGGCGGCGGAACAGATGAAGAAGTGGAGAAATTGAGGAGCTTCGCGAGATGTATTGGATTATTGTATCAAGTAGTAGATGATATACTCGATGTTACAAAGTCGTCGGAGGAACTCGGAAAAACCGCCGGAAAAGATTTGGCAGTAGATAAAACGACGTATCCAAAACTGCTGGGATTGGAAAAGGCTAAGGAATTTGCGGCGGAGCTCAACCGAGATGCTAAACAACAGCTGGTGGAATTTGATCCACACAAAGCTGCTCCCTTGATTGCTTTGGCGGATTACATTGCTTATCGTGAAAAT。

furthermore, the inventors have performed different combination type mutations at amino acid positions 154, 161, 209, 218 and 233, synthesized expression vectors with different combination mutations by using the existing genetic engineering technology, further constructed different strains by using the construction method of the geranylgeranyl diphosphate synthase (GGPPS) recombinant engineering strain in example 2, and examined the synthetic amount of beta-carotene. The specific test results are summarized below.

The results of the single-site experiments shown in FIGS. 1 to 5 show that:

when the 154 th Val is mutated into Ala or Cys, the 161 th Ile is mutated into Leu or Met, the 209 th Ile is mutated into Lys, Ser, aspartic acid Asp, asparagine Asn, alanine Ala and proline Pro, the 218 th Phe is mutated into Leu or Tyr, and the 233 th Val is mutated into Glu or Tyr, the color of the thallus or the synthetic amount of the beta-carotene is obviously improved;

as shown in FIGS. 6 to 8, the results of the two-site, three-site and five-site experiments show that the color of the cells or the amount of synthesized beta-carotene is significantly increased under the condition of different site combinations in a specific mutation direction.

The results show that the GGPPS enzyme activity can be better provided by aiming at the directional mutation evolution mode of a specific site, so that a good foundation is laid for further providing the beta-carotene content in crops.

Example 4

Based on the analysis and verification of example 3, the inventors further analyzed the GGPPS modification sites of the existing mainstream crops. The results of comparative analysis of amino acid sequences (as shown in FIG. 9, FIG. 9 shows only the 154-position comparison results) indicate that: similar to GGPPS of tobacco, the mainstream crops of pepper (cagggpps 1), potato (StGGPPS 1), wheat (tagggpps 1), corn (ZmGGPPS 1), salvia miltiorrhiza (SmGGPPS 1), coffee (CanGGPPS 1), carrot (DcGGPPS 1), grape (VvGGPPS), cucumber (csagpps), watermelon (ClGGPPS), apple (MdGGPPS 1), orange (csigpps), rubber tree (HbGGPPS), chrysanthemum (CmGGPPS), rice (OsGGPPS 1), tomato (SlGGPPS 1), castor bean (rcgggpps), banana (magggpps) and ginkgo biloba (GbGGPPS) all have 5 sites of GGPPS enzyme conserved, so that mutation modes based on the same site are feasible, or directional muteins obtained by the present application are directly utilized, and a new idea is provided for breeding of new varieties of these crops.

SEQUENCE LISTING

<110> Zhengzhou tobacco institute of China tobacco general Co

<120> GGPPS directed single point mutant protein GGPPS-233

<130>none

<160>2

<170>PatentIn version 3.5

<210>1

<211>296

<212>PRT

<213>Nicotiana tabacum

<400>1

Glu Gln Phe Asn Phe Lys Thr Tyr Val Ala Glu Lys Ala Ile Ser Val

1 5 10 15

Asn Lys Ala Leu Asp Glu Ala Val Ile Val Lys Asp Pro Pro Val Ile

20 25 30

His Glu Ala Met Arg Tyr Ser Leu Leu Ala Gly Gly Lys Arg Val Arg

35 40 45

Pro Met Leu Cys Leu Ala Ala Cys Glu Leu Val Gly Gly Asp Gln Ser

50 5560

Asn Ala Met Pro Ala Ala Cys Ala Val Glu Met Ile His Thr Met Ser

65 70 75 80

Leu Ile His Asp Asp Leu Pro Cys Met Asp Asn Asp Asp Leu Arg Arg

85 90 95

Gly Lys Pro Thr Asn His Lys Val Tyr Gly Glu Asp Val Ala Val Leu

100 105 110

Ala Gly Asp Ser Leu Leu Ala Phe Ala Phe Glu Tyr Ile Ala Thr Ala

115 120 125

Thr Ala Gly Val Ser Pro Ser Arg Ile Leu Ala Ala Ile Gly Glu Leu

130 135 140

Ala Lys Ser Ile Gly Thr Glu Gly Leu Val Ala Gly Gln Val Ala Asp

145 150 155 160

Ile Ala Cys Thr Gly Asn Pro Asn Val Gly Leu Asp Thr Leu Glu Phe

165 170 175

Ile His Ile His Lys Thr Ala Ala Leu Leu Glu Ala Ser Val Val Leu

180 185 190

Gly Ala Ile Leu Gly Gly Gly Thr Asp Glu Glu Val Glu Lys Leu Arg

195 200 205

Ile Phe Ala Arg Cys Ile Gly Leu Leu Phe Gln Val Val Asp Asp Ile

210 215220

Leu Asp Val Thr Lys Ser Ser Glu Val Leu Gly Lys Thr Ala Gly Lys

225 230 235 240

Asp Leu Ala Val Asp Lys Thr Thr Tyr Pro Lys Leu Leu Gly Leu Glu

245 250 255

Lys Ala Lys Glu Phe Ala Ala Glu Leu Asn Arg Asp Ala Lys Gln Gln

260 265 270

Leu Val Glu Phe Asp Pro His Lys Ala Ala Pro Leu Ile Ala Leu Ala

275 280 285

Asp Tyr Ile Ala Tyr Arg Glu Asn

290 295

<210>2

<211>888

<212>DNA

<213>Nicotiana tabacum

<400>2

gagcaattca atttcaaaac ttacgtagct gaaaaggcta tttctgtaaa taaagcttta 60

gatgaggctg ttatagtaaa agacccacct gtgatccacg aagcaatgcg ctattcactt 120

ctcgccggcg gcaaaagagt ccgaccgatg ctctgcctcg ccgcctgcga gctcgtcggc 180

ggcgaccaat ccaacgccat gccggctgct tgcgccgtcg agatgatcca cactatgtcc 240

ctcattcacg acgatttacc ttgtatggat aacgacgatc tccgccgtgg aaagccgacg 300

aaccacaaag tctacggcga ggacgtggcg gtcctcgccg gagactcgct cctcgctttc 360

gccttcgagt acatcgccac cgctaccgcc ggagtttcac cgtcgaggat cctcgccgcc 420

atcggcgaac tggcgaaatc catcggaact gaagggttag tagctggaca agtagcggat 480

atagcttgta ctggtaaccc taatgttgga ctcgacacac tcgaattcat tcacatacac 540

aaaacggcgg cgcttctaga agcttccgta gttctcggag caatcctcgg cggcggaaca 600

gatgaagaag tggagaaatt gaggatattc gcgagatgta ttggattatt gtttcaagta 660

gtagatgata tactcgatgt tacaaagtcg tcggaggtgc tcggaaaaac cgccggaaaa 720

gatttggcag tagataaaac gacgtatcca aaactgctgg gattggaaaa ggctaaggaa 780

tttgcggcgg agctcaaccg agatgctaaa caacagctgg tggaatttga tccacacaaa 840

gctgctccct tgattgcttt ggcggattac attgcttatc gtgaaaat 888

Claims

The GGPPS directional single-point mutant protein GGPPS-233 is characterized in that compared with the existing tobacco GGPPS protein, the 233 th amino acid Val is mutated into the acidic amino acid Glu or tyrosine Tyr;

the base sequence of the existing tobacco GGPPS protein is shown in SEQ ID NO. 1.
2. The use of the GGPPS directed single point mutant protein GGPPS-233 of claim 1 in pigment synthesis for the catalytic production of GGPP to synthesize beta-carotene.
3. The recombinant expression vector pET-32b (+) -GGPPS for expressing the GGPPS directed single-point mutein GGPPS-233 of claim 1, characterized in that the coding gene of the directed single-point mutein GGPPS-233 is recombined in pET-32b (+) plasmid.
4. The GGPPS directed single-point mutant protein GGPPS-233 of claim 1 is applied to the cultivation of new crop species, and is characterized in that the site directionally designed by GGPPS-233 is used for modifying the GGPPS gene of mainstream crops or recombining the directed single-point mutant protein GGPPS-233 into the genome of crops by using a genetic engineering technical means to adjust the content of pigment substances in the crops;

the pigment substance is beta-carotene.
5. The GGPPS directed single point mutant protein GGPPS-233 as claimed in claim 4, which is used in the cultivation of new varieties of crops, wherein the crops are: tobacco, pepper, tomato, rice, corn, wheat, potato, castor-oil plant, apple, cucumber, watermelon, carrot, banana, orange, grape, coffee, ginkgo, salvia, chrysanthemum or rubber tree.